Wordt geladen...
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
PURPOSE: We investigated whether irinotecan plus capecitabine improved progression-free survival (PFS) compared with capecitabine alone in patients with human epidermal growth factor 2 (HER2) negative and anthracycline and taxane pretreated metastatic breast cancer (MBC). MATERIALS AND METHODS: A to...
Bewaard in:
| Gepubliceerd in: | Cancer Res Treat |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Korean Cancer Association
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6333992/ https://ncbi.nlm.nih.gov/pubmed/29458237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2017.562 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|